Biotech News

PacBio to Report Third Quarter 2026 Financial Results on November 4, 2026

Pacific Biosciences (PACB)Pacific BiosciencesEarnings

PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2026 financial results on Wednesday, November 4, 2026, at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time).

Related news

Pacific Biosciences

Long-Read Sequencing Pacific Biosciences, or PacBio, develops high-accuracy long-read sequencing systems used in research and clinical genomics. Its HiFi technology reads long DNA fragments while maintaining high base-level accuracy. Sequencing Platforms The company's instrument portfolio includes high-throughput Revio systems and...

Recent company news

Stock data

Close
1.76 USD
Market cap
490.75M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States